Pfizer (PFE) Acquisitions (2009 - 2023)

Pfizer (PFE) posted quarterly Acquisitions of $43.4 billion for Q4 2023, up 173520.0% quarter-over-quarter from $25.0 million in Q3 2023.

Pfizer (PFE) Acquisitions (2009 - 2023) Analysis & Trends

Pfizer (PFE) has reported Acquisitions for 10 consecutive years, with $43.4 billion the latest figure, recorded in Q4 2023.

In Q4 2023, Acquisitions changed N/A year-over-year to $43.4 billion; the TTM figure through Sep 2024 stood at $43.4 billion (changed N/A YoY), while the FY2025 annual figure was $6.9 billion, changed N/A from the prior year.
Acquisitions grew to $43.4 billion in Q4 2023 per PFE's latest filing, from $25.0 million in the prior quarter.
Across five years, Acquisitions topped out at $43.4 billion in Q4 2023 and bottomed at $25.0 million in Q3 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Acquisitions (Qtr)
1	Johnson & Johnson	653.56 Bn	632.80 Bn	17.26 Bn	-17.24 Bn
2	AbbVie	469.72 Bn	463.15 Bn	12.70 Bn	-
3	Merck	377.32 Bn	370.18 Bn	12.21 Bn	-
4	Novartis Ag	302.80 Bn	295.11 Bn	11.24 Bn	-
5	Astrazeneca	258.16 Bn	253.26 Bn	12.86 Bn	-
6	Amgen	237.16 Bn	223.17 Bn	7.24 Bn	-
7	Gilead Sciences	183.24 Bn	180.06 Bn	6.22 Bn	11.21 Bn
8	Pfizer	160.63 Bn	148.93 Bn	10.94 Bn	-
9	Gsk	106.06 Bn	101.89 Bn	8.24 Bn	-
10	Sanofi	55.31 Bn	47.93 Bn	10.79 Bn	-

Download Data